Prosecution Insights
Last updated: August 18, 2026

Examiner: NGUYEN, JOHN P

Tech Center 1600 • Art Units: 1619

This examiner grants 44% of resolved cases

Performance Statistics

44.1%
Allow Rate
-15.9% vs TC avg
442
Total Applications
+41.5%
Interview Lift
1174
Avg Prosecution Days
Based on 406 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
5.8%
§102 Novelty
57.2%
§103 Obviousness
20.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17054441 SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY Non-Final OA NORTHWESTERN UNIVERSITY
17636209 Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders Non-Final OA Arizona Board of Regents on behalf of Arizona State University
18329944 METHODS FOR IMPROVING HEALTH OF FISH, USE OF ZINC OXIDE PARTICLES FOR THE PREPARATION OF FISH FEED, METHODS FOR PREPARING FISH FEED FOR FISH, AND FISH FEED THEREOF Non-Final OA City University of Hong Kong
18073852 DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS Non-Final OA YALE UNIVERSITY
18066945 TOPICAL PHARMACEUTICAL COMPOSITIONS Final Rejection Dermavant Sciences GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month